Published in Arch Gen Psychiatry on June 01, 2009
Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry (2011) 1.76
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine Tob Res (2010) 1.13
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding. J Nucl Med (2010) 1.10
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.07
Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers. Int J Neuropsychopharmacol (2012) 1.06
Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial. JAMA Psychiatry (2014) 1.06
Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity. Neuropharmacology (2013) 1.01
Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology (2013) 0.98
Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia. Am J Psychiatry (2012) 0.97
Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans. Neuropharmacology (2013) 0.95
Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Arch Gen Psychiatry (2011) 0.93
Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers. Am J Psychiatry (2013) 0.92
Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice. Neuropsychopharmacology (2012) 0.92
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors. Biochem Pharmacol (2011) 0.90
The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation. Neuropharmacology (2012) 0.90
SPECT imaging of nicotinic acetylcholine receptors in nonsmoking heavy alcohol drinking individuals. Drug Alcohol Depend (2010) 0.89
Inside-out neuropharmacology of nicotinic drugs. Neuropharmacology (2015) 0.89
Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density. Neuropsychopharmacology (2013) 0.88
Effects of Menthol on Nicotine Pharmacokinetic, Pharmacology and Dependence in Mice. PLoS One (2015) 0.88
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia. Curr Pharm Des (2014) 0.86
Craving among long-abstinent smokers: an Internet survey. Nicotine Tob Res (2010) 0.85
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. Neuropsychopharmacology (2013) 0.84
nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. Schizophr Res (2016) 0.84
In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia. Biol Psychiatry (2013) 0.83
Imaging receptor changes in human drug abusers. Curr Top Behav Neurosci (2010) 0.83
Beta2* nicotinic acetylcholine receptors modulate pain sensitivity in acutely abstinent tobacco smokers. Nicotine Tob Res (2010) 0.82
Withdrawal: Expanding a Key Addiction Construct. Nicotine Tob Res (2015) 0.82
Brain imaging of nicotinic receptors in Alzheimer's disease. Int J Alzheimers Dis (2010) 0.82
Changes in the α4β2* nicotinic acetylcholine system during chronic controlled alcohol exposure in nonhuman primates. Drug Alcohol Depend (2014) 0.82
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain. J Neurochem (2014) 0.80
Ovarian hormones and drug abuse. Curr Psychiatry Rep (2014) 0.80
Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors. Br J Pharmacol (2015) 0.79
Measuring α4β2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate. J Cereb Blood Flow Metab (2013) 0.79
Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice. Psychopharmacology (Berl) (2014) 0.78
Nicotinic receptor contributions to smoking: insights from human studies and animal models. Curr Addict Rep (2015) 0.78
Translational research in nicotine dependence. Cold Spring Harb Perspect Med (2013) 0.77
Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice. Behav Neurosci (2014) 0.77
How to design PET experiments to study neurochemistry: application to alcoholism. Yale J Biol Med (2014) 0.77
Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms. J Neural Transm (Vienna) (2011) 0.76
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies. J Clin Pharm Ther (2014) 0.76
Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. J Nucl Med (2015) 0.76
Selegiline transdermal system (STS) as an aid for smoking cessation. Nicotine Tob Res (2011) 0.76
Smoking and Neuroimaging: A Review. Curr Cardiovasc Risk Rep (2011) 0.75
Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence. Psychopharmacology (Berl) (2016) 0.75
A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. Mol Psychiatry (2016) 0.75
Nicotinic modulation of salience network connectivity and centrality in schizophrenia. J Psychiatr Res (2017) 0.75
CHRNA4 and ANKK1 Polymorphisms Influence Smoking-Induced Nicotinic Acetylcholine Receptor Upregulation. Nicotine Tob Res (2016) 0.75
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence. Neuropharmacology (2017) 0.75
Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain. Neuroimage (2016) 0.75
Nicotinic acetylcholine receptor availability in cigarette smokers: effect of heavy caffeine or marijuana use. Psychopharmacology (Berl) (2016) 0.75
Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [(11)C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology (2017) 0.75
Regular moist snuff dipping does not affect endurance exercise performance. PLoS One (2017) 0.75
Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation. Elife (2017) 0.75
Effects of ceftriaxone on conditioned nicotine reward in rats. Behav Pharmacol (2017) 0.75
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res (2007) 5.57
The development and initial validation of a questionnaire on smoking urges. Br J Addict (1991) 4.77
Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31
Remembering the past: two facets of episodic memory explored with positron emission tomography. Am J Psychiatry (1995) 3.71
Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci (2004) 3.27
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol (1992) 3.20
An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J Appl Behav Anal (1996) 2.98
It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol (2007) 2.85
Cerebellum implicated in sensory acquisition and discrimination rather than motor control. Science (1996) 2.71
Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry (2002) 2.60
Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev (2005) 2.59
Primary motor and sensory cortex activation during motor performance and motor imagery: a functional magnetic resonance imaging study. J Neurosci (1996) 2.56
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry (2006) 2.53
Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci (2007) 2.37
Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci (1999) 2.35
Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem (1988) 2.24
Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry (2007) 2.23
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature (1999) 2.13
Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther (2008) 2.04
Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci (2006) 1.99
Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther (1997) 1.98
Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther (2005) 1.96
Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron (2005) 1.89
Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry (2001) 1.84
Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science (1983) 1.78
The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) (2006) 1.76
Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology (Berl) (2005) 1.76
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci (2003) 1.73
Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther (1999) 1.73
The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol (1992) 1.69
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol (1994) 1.68
5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol (2000) 1.67
Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology (Berl) (1984) 1.59
Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics (2007) 1.56
The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J Neurochem (2007) 1.53
Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380. J Nucl Med (2008) 1.51
Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry (2005) 1.47
Contingent payment procedures for smoking reduction and cessation. J Appl Behav Anal (1986) 1.45
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther (1985) 1.39
beta2-Subunit-containing nicotinic acetylcholine receptors are involved in nicotine-induced increases in conditioned reinforcement but not progressive ratio responding for food in C57BL/6 mice. Psychopharmacology (Berl) (2005) 1.38
PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry (2003) 1.38
The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology (2002) 1.36
Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther (2003) 1.35
Long-term nicotine treatment decreases striatal alpha 6* nicotinic acetylcholine receptor sites and function in mice. Mol Pharmacol (2005) 1.34
A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments. Appl Psychophysiol Biofeedback (2005) 1.33
Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs (2001) 1.31
Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function. Mol Pharmacol (2008) 1.30
The preparation and readiness for voluntary movement: a high-field event-related fMRI study of the Bereitschafts-BOLD response. Neuroimage (2003) 1.28
Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology (2004) 1.23
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J Neurochem (2001) 1.21
An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther (1991) 1.19
Beta2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration. Neuropharmacology (2004) 1.17
Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study. J Nucl Med (2007) 1.17
Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine Tob Res (2004) 1.16
An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine. J Biol Chem (2004) 1.15
Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology (2003) 1.15
Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berl) (2005) 1.14
123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility. J Nucl Med (2005) 1.14
Contingent reinforcement for reduced breath carbon monoxide levels: target-specific effects on cigarette smoking. Addict Behav (1985) 1.12
Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. Psychopharmacology (Berl) (2006) 1.11
Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. J Neurosci (2002) 1.11
Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc Natl Acad Sci U S A (2007) 1.08
Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology (Berl) (1999) 1.07
Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys. J Pharmacol Exp Ther (2006) 1.07
Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem (1997) 1.07
Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. Prog Brain Res (1989) 1.06
Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors. J Physiol (2006) 1.04
Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families. Curr Med Chem (2003) 1.04
Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects. Eur J Nucl Med Mol Imaging (2002) 1.03
Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates. Nucl Med Biol (2001) 1.00
Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors. Neuropharmacology (1985) 1.00
Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond. Nicotine Tob Res (2004) 0.99
Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment. J Neurochem (2006) 0.99
Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. Neurobiol Aging (2008) 0.98
Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci (1997) 0.97
(S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner. J Pharmacol Exp Ther (1999) 0.97
Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina. J Neurochem (2003) 0.94
Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.94
In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci (1998) 0.90
Self-administration of 5-iodo-A-85380, a beta2-selective nicotinic receptor ligand, by operantly trained rats. Neuroreport (2003) 0.88
Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors. Brain Res Bull (1990) 0.87
5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects. Ann Nucl Med (2004) 0.82
Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors. Nucl Med Biol (1999) 0.81
Chemical fate of the nicotinic acetylcholinergic radiotracer [123I]5-IA-85380 in baboon brain and plasma. Nucl Med Biol (2006) 0.77
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA (2008) 11.32
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry (2008) 4.91
Religious coping and use of intensive life-prolonging care near death in patients with advanced cancer. JAMA (2009) 4.04
Prolonged grief disorder: Psychometric validation of criteria proposed for DSM-V and ICD-11. PLoS Med (2009) 3.80
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) (2002) 3.74
Temporal lobe and "default" hemodynamic brain modes discriminate between schizophrenia and bipolar disorder. Hum Brain Mapp (2008) 3.54
Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry (2007) 3.02
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology (2004) 2.87
Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome. Addict Behav (2005) 2.45
Racial differences in predictors of intensive end-of-life care in patients with advanced cancer. J Clin Oncol (2009) 2.36
Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferences. J Clin Oncol (2008) 2.30
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry (2005) 2.28
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) (2003) 2.28
Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry (2009) 2.25
Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol Psychiatry (2010) 2.16
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects. J Nucl Med (2012) 2.16
Health correlates of recreational gambling in older adults. Am J Psychiatry (2004) 2.08
Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav (2013) 2.07
Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci (2006) 1.99
Modeling the effect of alcohol on smoking lapse behavior. Psychopharmacology (Berl) (2006) 1.95
Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med (2005) 1.89
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med (2006) 1.78
Psychotic depression and mortality. Am J Psychiatry (2003) 1.78
Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry (2003) 1.77
Sex differences in the effects of stressful life events on changes in smoking status. Addiction (2003) 1.77
Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset. Arch Gen Psychiatry (2004) 1.68
Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res (2005) 1.67
Grief and acceptance as opposite sides of the same coin: setting a research agenda to study peaceful acceptance of loss. Br J Psychiatry (2008) 1.64
Peaceful awareness in patients with advanced cancer. J Palliat Med (2006) 1.59
Video-gaming among high school students: health correlates, gender differences, and problematic gaming. Pediatrics (2010) 1.56
Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain (2011) 1.55
Childhood maltreatment as a risk factor for adult cardiovascular disease and depression. J Clin Psychiatry (2004) 1.52
Gender differences in adolescent gambling. Ann Clin Psychiatry (2006) 1.51
Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress. Proc Natl Acad Sci U S A (2009) 1.49
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology (2008) 1.49
Minor cognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care. J Pain Symptom Manage (2012) 1.47
Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine Tob Res (2008) 1.46
Chest radiograph as a triage tool in the imaging-based diagnosis of pulmonary embolism. AJR Am J Roentgenol (2005) 1.46
Stealing among high school students: prevalence and clinical correlates. J Am Acad Psychiatry Law (2011) 1.43
Gender differences in adolescent marijuana use and associated psychosocial characteristics. J Addict Med (2011) 1.42
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) (2004) 1.38
Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry (2002) 1.35
Mental health, treatment preferences, advance care planning, location, and quality of death in advanced cancer patients with dependent children. Cancer (2009) 1.35
Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry (2005) 1.33
Selective frontal, parietal, and temporal networks in generalized seizures. Neuroimage (2003) 1.33
Impulsive sensation seeking, parental history of alcohol problems, and current alcohol and tobacco use in adolescents. J Addict Med (2008) 1.28
Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol Psychiatry (2007) 1.28
Knowledge and perceived risk of smoking-related conditions: a survey of cigarette smokers. Prev Med (2005) 1.28
Population attributable fractions of psychiatric disorders and behavioral outcomes associated with combat exposure among US men. Am J Public Health (2002) 1.28
Correlates of at-risk/problem internet gambling in adolescents. J Am Acad Child Adolesc Psychiatry (2010) 1.26
Impact of family burden and affective response on clinical outcome among patients with bipolar disorder. Psychiatr Serv (2004) 1.25
Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration. Psychopharmacology (Berl) (2007) 1.24
A cost-analysis of adopting a healthful diet in a family-based obesity treatment program. J Am Diet Assoc (2002) 1.20
Smoking comorbidity in alcoholism: neurobiological and neurocognitive consequences. Alcohol Clin Exp Res (2006) 1.20
Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats. Am J Addict (2007) 1.20
Problematic Internet use and health in adolescents: data from a high school survey in Connecticut. J Clin Psychiatry (2011) 1.20
Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence. Drug Alcohol Depend (2008) 1.19
(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol (2004) 1.19
Sources of prescriptions for misuse by adolescents: differences in sex, ethnicity, and severity of misuse in a population-based study. J Am Acad Child Adolesc Psychiatry (2009) 1.18
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology (2002) 1.17
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale. Psychol Addict Behav (2007) 1.17
A gender-based examination of past-year recreational gamblers. J Gambl Stud (2006) 1.15
Characterizing adolescent prescription misusers: a population-based study. J Am Acad Child Adolesc Psychiatry (2008) 1.15
Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry (2004) 1.15
123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility. J Nucl Med (2005) 1.14
Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol (2006) 1.12
Smoking expectancies, weight concerns, and dietary behaviors in adolescence. Pediatrics (2010) 1.12
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res (2008) 1.12
Contingency management for smoking cessation: enhancing feasibility through use of immunoassay test strips measuring cotinine. Nicotine Tob Res (2008) 1.12
Tobacco use across the formative years: a road map to developmental vulnerabilities. Nicotine Tob Res (2003) 1.11
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding. J Nucl Med (2010) 1.10
Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval. J Expo Sci Environ Epidemiol (2010) 1.10
Randomized trial: Quitline specialist training in gain-framed vs standard-care messages for smoking cessation. J Natl Cancer Inst (2010) 1.09
Health/functioning characteristics, gambling behaviors, and gambling-related motivations in adolescents stratified by gambling problem severity: findings from a high school survey. Am J Addict (2011) 1.09
Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry (2005) 1.09
Daily patterns of alcohol, cigarette, and marijuana use in adolescent smokers and nonsmokers. Addict Behav (2005) 1.09
Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates. Neuroimage (2012) 1.08
Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology (2007) 1.08
123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase. J Nucl Med (2007) 1.08